COMMUNIQUÉS West-GlobeNewswire

Shire plc : Rule 2.9 announcement
27/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 27 June 2018 Shire [...]
Dividend payment ex-date of AS “Latvijas Jūras medicīnas centrs”
27/06/2018
Latvia, 2018-06-27 07:52 CEST (GLOBE NEWSWIRE) -- AS “Latvijas Jūras medicīnas centrs” (LJM1R, ISIN code LV0000100741) will close the list of shareholders for dividend payment on July 2, 2018 at the end of the working [...]
ThromboGenics Plans Name Change to "Oxurion"
27/06/2018
To better reflect Company's activities and ambition to deliver best in class therapies for back of the eye disorders Press release - Regulated Information Leuven, Belgium, 27 June 2018 - ThromboGenics NV (Euronext [...]
MDxHealth's SelectMDx Test Successfully Stratifies Men
27/06/2018
NEWS RELEASE MDxHealth's SelectMDx Test Successfully Stratifies Men Who May Benefit from mp-MRI Multiple SelectMDx Clinical Study Abstracts presented at 2018 Global Prostate Congress in Frankfurt, Germany HERSTAL, [...]
Le test SelectMDx de MDxHealth classe avec succès les hommes
27/06/2018
COMMUNIQUÉ DE PRESSE Le test SelectMDx de MDxHealth classe avec succès les hommes qui peuvent bénéficier de l'IRMmp De nombreux résumés d'étude clinique de SelectMDx présentés au congrès mondial sur le cancer de la [...]
Biocartis Group NV: Study Reviewing 2,500 Performed Idylla(TM) Tests Shows Generation of Valid Results in 98.1% of Cases and Outperformance over Reference Methods
27/06/2018
PRESS RELEASE : 27 June 2018, 07:00 CEST Study Reviewing 2,500 Performed Idylla(TM) Tests Shows Generation of Valid Results in 98.1% of Cases and Outperformance over Reference Methods Mechelen, Belgium, 27 June 2018 - [...]
iTeos Therapeutics Expands Board of Directors with the Appointment of David Hallal as Chairman and Tim Van Hauwermeiren as an Independent Director
27/06/2018
iTeos Therapeutics Expands Board of Directors with the Appointment of David Hallal as Chairman and Tim Van Hauwermeiren as an Independent Director Two new appointments follow oversubscribed $75 million (€64 million) [...]
Assure Holdings Corp. Announces Update
27/06/2018
DENVER, June 26, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV:IOM) (OTCQB:ARHH) is providing an update relating to the Management Cease Trade Order (“ MCTO ”), effective May 1, [...]
Peer-reviewed Neurology Publication on Medibio Science
27/06/2018
SYDNEY, Australia and MINNEAPOLIS, June 26, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company ) (ASX:MEB) (OTCQB:MDBIF), a mental health technology company, announces that a clinical article by Defillo et al [...]
Image Following Treatment with 177Lu-PSMA-617 Selected by Society of Nuclear Medicine and Molecular Imaging as Image of the Year
27/06/2018
Image depicts PSMA PET scans of eight patients with exceptional responses from investigator-sponsored Phase 2 study WEST LAFAYETTE, Ind., June 26, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a [...]
Neon Therapeutics Announces Pricing of Initial Public Offering
27/06/2018
CAMBRIDGE, Mass., June 26, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq:NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced the pricing of its initial [...]
Pain Therapeutics Announces Results of FDA Advisory Committee Meeting for REMOXY ER
26/06/2018
AUSTIN, Texas, June 26, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE), a drug development company, today announced that a joint meeting of the Anesthetic and Analgesic Drug Products Advisory Committee [...]
Dentsply Sirona Declares Quarterly Cash Dividend
26/06/2018
YORK, Pa., June 26, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ:XRAY), The Dental Solutions Company TM , announced that its Board of Directors declared a quarterly cash dividend of $0.0875 [...]
VistaGen Therapeutics Reports Fiscal Year 2018 Financial Results and Provides Year-to-Date Highlights
26/06/2018
AV-101, VistaGen’s Oral NMDA Receptor Modulator, Granted FDA Fast-Track Designation for Major Depressive Disorder Key AV-101 Patents Issued in U.S., Europe and Asia ELEVATE, AV-101 U.S. Phase 2 Major Depressive Disorder [...]
Apellis Pharmaceuticals Announces First Patient Enrolled in Phase 3 APL-2 Head-to-Head Study in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Treated with Soliris™
26/06/2018
CRESTWOOD, Ky., and WALTHAM Mass., June 26, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Globus Medical Announces ExcelsiusGPS® Milestone: 3,000 screws implanted
26/06/2018
Study demonstrates potential to improve spine surgery techniques by combining robotics and navigation AUDUBON, Pa., June 26, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions [...]
Xeris Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
26/06/2018
CHICAGO, June 26, 2018 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (NASDAQ:XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and [...]
Medigus Enters Orthopedic Market with New Development and Manufacturing Agreement for Integrated Visualization Device with A.M. Surgical Inc.
26/06/2018
Project size $780,000 The integrated visuation device is designated to provide surgical control and visualization during endoscopic carpal tunnel releases; hundreds of thousands of procedures performed annually in the [...]
Amicus Therapeutics Announces European Regulatory and Clinical Updates for AT-GAA in Pompe Disease
26/06/2018
CRANBURY, N.J., June 26, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company focused on discovering, developing and delivering novel medicines for rare metabolic diseases, [...]

Pages